A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer - Related Studies

Home

A Safety Trial of MVA-BN®-PRO in Men With Androgen-Insensitive Prostate Cancer (BNIT-PR-001)

This study is currently recruiting participants.

Study NCT00629057. Last updated on July 7, 2008. Information provided by BN ImmunoTherapeutics

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Prostatic Neoplasms

2	More general conditions related to this trial
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Site
		Prostatic Diseases
		Urogenital Neoplasms

3	Interventions listed in this trial
		MVA-BN-PRO

4	Sponsors listed in this trial
		BN ImmunoTherapeutics